Come up with a name for your new list and we'll add to it:
Innovative Biologics raised a round of funding on October 24, 2007. Investors include
CIT GAP Funds.
IBI has recently demonstrated that treatment of Bacillus anthracis infected mice with a combination of the antibiotic ciprofloxacin and partially purified antibodies against anthrax protective antigen…